Question 1

What is the catalog number for (4S,4'S) -2,2'- (Pent-4-yne-2,2-diyl) bis (4-phenyl-4,5-dihydrooxazole)?

Accepted Answer

The catalog number for (4S,4'S) -2,2'- (Pent-4-yne-2,2-diyl) bis (4-phenyl-4,5-dihydrooxazole) is OR1060110.

Question 2

What sizes are available for (4S,4'S) -2,2'- (Pent-4-yne-2,2-diyl) bis (4-phenyl-4,5-dihydrooxazole)?

Accepted Answer

(4S,4'S) -2,2'- (Pent-4-yne-2,2-diyl) bis (4-phenyl-4,5-dihydrooxazole) is available in the following size(s): 100 mg, 250 mg, 1 g.

Question 3

How many pack sizes does (4S,4'S) -2,2'- (Pent-4-yne-2,2-diyl) bis (4-phenyl-4,5-dihydrooxazole) come in?

Accepted Answer

(4S,4'S) -2,2'- (Pent-4-yne-2,2-diyl) bis (4-phenyl-4,5-dihydrooxazole) is available in 3 different pack sizes.

Question 4

Is (4S,4'S) -2,2'- (Pent-4-yne-2,2-diyl) bis (4-phenyl-4,5-dihydrooxazole) in stock?

Accepted Answer

(4S,4'S) -2,2'- (Pent-4-yne-2,2-diyl) bis (4-phenyl-4,5-dihydrooxazole) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 7

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

(4S,4'S) -2,2'- (Pent-4-yne-2,2-diyl) bis (4-phenyl-4,5-dihydrooxazole)

Product Specifications

CAS Number

Purity

Smiles

Available Sizes

Frequently Asked Questions

Explore Other Products

Gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker) (PMEL/2039), Biotin conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), CF740 conjugate, 0.1mg/mL

CD45 / LCA (2B11 + PD7/26), Biotin conjugate, 0.1mg/mL

Cytokeratin, pan (Epithelial Marker) (KRTH/1576R + KRTL/1577R), CF488A conjugate, 0.1mg/mL

Vimentin (Mesenchymal Cell Marker) (V9), CF568 conjugate, 0.1mg/mL

Cytokeratin 8 (KRT8/803), CF405S conjugate, 0.1mg/mL